Print

ANRS VAC 12

A study of the safety and immunogenicity of LPHIV1, a mixture of HIV-derived lipopeptides, in HIV-negative, healthy adult volunteers

Trial Details:

I Completed
French National Agency for Research on AIDS and viral hepatitis (ANRS); Biovector Therapeutics May 01, 2001
LPHIV1 gag, pol-rt, pol and nef
LPHIV1 Protein
France 15
http://www.anrs.fr/